Search results for “Cognitive Symptoms” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 83 patents, we discovered top 23 key players by total patent application. Pfizer Inc., Cavion, Inc., GW Research Ltd. are dominant in this area. They take 37.35% of the total patent filing.
Pfizer Inc.
New York, United States
Patent: 16
Cavion, Inc.
Virginia, United States
Patent: 9
GW Research Ltd.
Cambridgeshire, United Kingdom
Patent: 6
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 5
Sanofi-Synthélabo SA
France
Patent: 5
GW Pharma Ltd.
Cambridgeshire, United Kingdom
Patent: 4
Panasonic Intellectual Property Management Co. Ltd.
Osaka-fu, Japan
Patent: 4
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 3
AFFiRiS AG
Niederösterreich, Austria
Patent: 3
Shanghai Hansoh Biomedical Co. Ltd.
Shanghai Shi, China
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Alto Neuroscience, Inc.
California, United States
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 34 patents applied in the last 5 years. We discover 12 most active companies in this area. The fast-growing Cavion, Inc., Pfizer Inc., Takeda Pharmaceutical Co., Ltd. take 61.76% of patent filing during this period.
Cavion, Inc.
Virginia, United States
Patent: 9
Pfizer Inc.
New York, United States
Patent: 7
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 5
Korea University Reserch & Business Foundation
South Korea
Patent: 4
Neurocrine Biosciences, Inc.
California, United States
Patent: 2
Korea Institute of Science & Technology
South Korea
Patent: 2
STARTUP
Alto Neuroscience, Inc.
California, United States
Patent: 2
Stichting Katholieke Universiteit
Gelderland, Netherlands
Patent: 1
GW Research Ltd.
Cambridgeshire, United Kingdom
Patent: 1
GW Pharma Ltd.
Cambridgeshire, United Kingdom
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 34 patents in last 5 years, we discover 8 new entrants. Cavion, Inc., Takeda Pharmaceutical Co., Ltd., Korea University Reserch & Business Foundation are the most active new entrants in this area.
Cavion, Inc.
Virginia, United States
Patent: 9
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 5
Korea University Reserch & Business Foundation
South Korea
Patent: 4
Neurocrine Biosciences, Inc.
California, United States
Patent: 2
STARTUP
Alto Neuroscience, Inc.
California, United States
Patent: 2
Stichting Katholieke Universiteit
Gelderland, Netherlands
Patent: 1
UCB Biopharma SRL
Belgium
Patent: 1
Neuraxpharm Italy SpA
Ascoli Piceno, Italy
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 17 patents, we discovered top 5 universities and scientific research institutions by total patent application. Kanazawa Medical University, Korea Institute of Science & Technology, Nagoya City University are dominant in this area. They take 76.47% of the total patent filing.
Kanazawa Medical University
Ishikawa-ken, Japan
Patent: 6
Korea Institute of Science & Technology
South Korea
Patent: 3
Nagoya City University
Aichi-ken, Japan
Patent: 2
Yale University
Connecticut, United States
Patent: 1
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: